Clinical Trial

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

Name: Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function — clinical trial record (NCT04530383)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-16

Trial Details

NCT Number	NCT04530383
Lead Sponsor	University of Kansas Medical Center
Conditions	Cystic Fibrosis-related Diabetes, Cystic Fibrosis
Enrollment	30 participants
Start Date	2022-02-14
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-07-15 (estimated)
Updated on ClinicalTrials.gov	2026-04-15